Whats Coming Orforglipron, Lillys oral GLP-1 (non-peptide), is in late-phase trials
How does Yunique Medical approach GLP-1 therapy differently
Its stable in gastric juice, which degrades most other protein molecules for digestion and absorption, so its commonly used in the treatment of a variety of gastrointestinal illnesses, including ulcers and Crohns disease
References Badenhorst, T., Svirskis, D., Wilsher, T., & O'Sullivan, J
never leave it in a hot car
A patient with diabetes medication, kidney concerns, low blood pressure, gallbladder history, or poor intake may require closer monitoring